Canlyniadau chwilio am the

In this 30-minute session designed for employers and managers of HCPC registrants, we’ll introduce the revisions and move on to consider the ways in which you can support your team to understand and embed the changes.

From midnight on 1st April 2019, gabapentin and pregabalin will be reclassified as Schedule 3 controlled drugs, under the Misuse of Drugs Regulations (2001), and Class C of the Misuse of Drugs Act (1971)

The way we communicate is continually evolving and our standards need to reflect this.

We’re proposing changes to our standards of education and training (SETs), which make sure that future health and care professionals trained in the UK are equipped to deliver safe and effective care.

We work closely with the other UK health regulators to share best practice

The standards against which we assess education and training programmes

View our response to the Department of Health (Northern Ireland) consultation

Details of our policies including equality, diversity and inclusion and the Welsh language scheme

More details about aspects of the performance review process.

The overall aim of this project is to explore ‘preparation for practice’ of newly qualified professionals who have completed pre-registration education and training programmes approved by the HCPC. Evidence gained from this project will inform and assist the HCPC in decision-making regarding the SETs (and supporting guidance) required when preparing newly qualified professionals to be fit to practise.

Our aim in this report is to be transparent about how we handle disclosures, highlight the action taken about these issues, and to improve collaboration across the health sector.

Our aim in this report is to be transparent about how we handle disclosures, highlight the action taken about these issues, and to improve collaboration across the health sector.

This policy statement sets out our broad approach to annotation of our Register